CHEBI:176399 - inclisiran
Main |
|
ChEBI Ontology |
|
Automatic Xrefs |
|
Reactions |
|
Pathways |
|
Models |
|
This entity has been annotated by a third party. If you would like more
information added to this entry, please contact ChEBI via
email
or
GitHub.
inclisiran |
|
CHEBI:176399 |
|
Inclisiran is a long-acting, synthetic small interfering RNA (siRNA) directed against PCSK9. It is indicated for the treatment of primary hypercholesterolemia (familial and non-familial) or mixed dyslipidemia in adults. |
|
This entity has been manually annotated by a third party.
|
|
Bijay
|
|
|
inclisiran
|
WHO MedNet
|
inclisirán
|
WHO MedNet
|
inclisiran
|
WHO MedNet
|
inclisiranum
|
WHO MedNet
|
ALN-60212
|
ChemIDplus
|
ALN-PCSsc
|
ChemIDplus
|
1639324-58-5
|
CAS Registry Number
|
ChemIDplus
|
24094767
|
PubMed citation
|
Europe PMC
|
|